FDA proposes uniform system for classifying protocol deviations

Regulatory NewsRegulatory NewsAdverse eventsClinical outcome assessmentClinical TrialsEthics/Professional ConductPharmaceuticalsRegulatory Intelligence/PolicyUnited States